Kodu・Aktsiate loetelu・Anika Therapeutics Inc

Anika Therapeutics Inc

Suletud

SektorTervishoid

13.35 -2.41

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.25

Max

13.44

Põhinäitajad
By Trading Economics
Sissetulek	-3.6M -311K
Müük	-2M 31M
Aktsiakasum	-0.01
Kasumimarginaal	-1.017
Töötajad	235
EBITDA	-5.6M -712K

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+71.64% upside

Turustatistika
By TradingEconomics
Turukapital	-65M 195M
Eelmine avamishind	15.76
Eelmine sulgemishind	13.35

Anika Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. nov 2026, 21:07 UTC

Anika Therapeutics Inc shares are declining sharply, closing significantly lower than Thursday's close and near the lower end of its one-month range.

12. nov 2026, 22:51 UTC

Anika Therapeutics Inc is trading higher in after-market hours, recovering to its highest point.

11. nov 2026, 21:06 UTC

Anika Therapeutics Inc is seeing a notable increase in its stock price, reflecting strong performance amid broader market gains since Tuesday's close.

10. nov 2026, 21:01 UTC

Anika Therapeutics Inc shares fell sharply, breaking a recent trend of higher daily closes and experiencing a downward shift from previous upward momentum.

9. nov 2026, 23:01 UTC

Anika Therapeutics Inc shares are trading modestly lower in after-market hours, reversing from an initial uptick and remaining below its 20-day moving average.

6. nov 2026, 21:02 UTC

News

Anika Therapeutics reports Q3 revenue of $30.6 million, exceeding expectations, but posts a net loss of $311K, leading to a negative market reaction.

5. nov 2026, 21:03 UTC

Anika Therapeutics Inc shares fell sharply, breaking a recent trend of higher daily closes and experiencing a downward shift from previous upward momentum.

4. nov 2026, 21:02 UTC

Anika Therapeutics Inc shares are advancing on Wednesday, despite a broader market experiencing a downward shift after a trend of higher daily closes since Tuesday.

3. nov 2026, 21:01 UTC

Anika Therapeutics Inc shares are declining, trading slightly lower and below the 20-day moving average, amid ongoing weakness in broader performance.

2. nov 2026, 21:04 UTC

Anika Therapeutics Inc shares fell sharply, reaching their lowest point and closing well below the 20-day moving average amid broader market weakness.

30. okt 2026, 20:02 UTC

Anika Therapeutics Inc shares fell sharply today, declining significantly from an initial peak at the market open and marking a notable decrease since Thursday's close.

29. okt 2026, 19:15 UTC

Anika Therapeutics Inc is trading roughly flat, having peaked earlier in the session before retracing slightly, while remaining above its 20-day moving average.

28. okt 2026, 20:52 UTC

Anika Therapeutics Inc is trading modestly lower in after-market hours, reflecting broader market declines influenced by recent economic data and the Fed's cautious outlook.

26. okt 2026, 20:06 UTC

Anika Therapeutics shares are declining, following a modest drop since Friday, amid broader market losses after five consecutive sessions of gains.

24. okt 2026, 00:01 UTC

Anika Therapeutics Inc is trading modestly lower in after-market hours, continuing a notable decline from recent higher finishes.

23. okt 2026, 23:11 UTC

Anika Therapeutics Inc is trading modestly lower in after-market hours, following a notable decline that ended regular trading at its lowest point.

22. okt 2026, 20:51 UTC

Anika Therapeutics Inc is experiencing a significant decline in after-market trading, moving lower after starting the session flat.

19. okt 2026, 20:01 UTC

Anika Therapeutics Inc shares are advancing, having reached a mid-day peak before pulling back slightly, while maintaining a position around the middle of its one-month range.

16. okt 2026, 20:01 UTC

Anika Therapeutics Inc shares are declining, reversing a trend of higher daily closes observed in recent sessions, diverging from upward momentum since Thursday's close.

14. okt 2026, 20:07 UTC

Anika Therapeutics Inc shares declined, settling near Tuesday's close after earlier rebounding from a session low.

12. okt 2026, 20:01 UTC

Anika Therapeutics Inc shares are advancing, continuing a sharp upward trajectory since Friday's close, despite broader market performance showing a decline.

9. okt 2026, 20:01 UTC

Anika Therapeutics Inc is trading higher, having gained significantly since Thursday's close, despite pulling back from a session high earlier today.

8. okt 2026, 20:07 UTC

Anika Therapeutics Inc shares declined significantly, closing near their lowest levels and well below the 20-day moving average during Thursday's session.

7. okt 2026, 19:20 UTC

Anika Therapeutics Inc is trading higher, reaching a peak return in the late afternoon despite remaining below its 20-day moving average.

6. okt 2026, 20:00 UTC

Anika Therapeutics Inc shares fell sharply, trading below their 20-day moving average and near the lower end of their one-month range.

5. okt 2026, 20:20 UTC

Anika Therapeutics Inc's shares rose in after-market trading, recovering from an initial dip to finish higher, despite being below its 20-day moving average.

2. okt 2026, 20:07 UTC

Anika Therapeutics Inc. shares fell, marking a fifth consecutive session of lower closes, and are currently below their 20-day moving average.

1. okt 2026, 20:07 UTC

Anika Therapeutics Inc shares fell, continuing a downward trend with notable weakness, marking four consecutive sessions of decline and remaining below the 20-day moving average.

30. sept 2026, 20:07 UTC

Anika Therapeutics Inc shares are declining, retracing from an early peak and currently positioned below their 20-day moving average.

29. sept 2026, 20:01 UTC

Anika Therapeutics Inc shares fell sharply, trading well below their 20-day moving average amid ongoing weakness in the biotechnology sector.

Võrdlus sarnastega

Hinnamuutus

Anika Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

71.64% tõus

12 kuu keskmine prognoos

Keskmine 23 USD 71.64%

Kõrge 23 USD

Madal 23 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Anika Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Anika Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.